Quality Executive Partners151Quality Executive Partners (QxP) and Virtuosi together form a differentiated advisory and enablement ecosystem purpose-built for today’s pharmaceutical and advanced therapy leaders.
QxP is a premium cGMP-focused consulting firm comprised of former pharmaceutical and biotechnology executives, quality leaders, and operations professionals with decades of global regulatory experience. The firm partners with pharmaceutical, biotech, CDMO, and ATMP organizations to mitigate enterprise risk, accelerate regulatory readiness, and drive sustainable performance across the product lifecycle. QxP’s commercial pillars span core quality and compliance, advanced therapies, and onshoring/reshoring—delivering integrated services across regulatory strategy and remediation, data integrity, QMS development, inspection readiness, technical operations, tech transfer and scale-up, workforce readiness, and interim leadership.
Virtuosi extends this impact through a modern digital learning platform purpose-built for regulated manufacturing environments. With immersive virtual reality experiences and streaming video coursework available in multiple languages, Virtuosi enables organizations to rapidly operationalize best practices, standardize execution, and build workforce capability at scale—supporting everything from aseptic technique and contamination control to inspection preparedness and operational excellence.
Together, QxP and Virtuosi operate as a force multiplier: QxP delivers hands-on executive advisory and technical execution, while Virtuosi embeds that expertise directly into frontline performance through scalable, experiential learning. This combination allows clients not only to solve immediate challenges, but also to institutionalize knowledge, reduce repeat risk, and accelerate time to readiness across global networks.
With deep industry and regulatory insight, a worldwide delivery footprint, and a practical, outcomes-driven approach, QxP and Virtuosi help pharmaceutical leaders move beyond remediation toward resilient, inspection-ready operations—transforming compliance into a strategic advantage.
